Atosiban Labatec 6.75 mg / 0.9 ml
As listed in the register: Atosiban Labatec 6.75 mg / 0.9 ml, solution injectable
6.75 mg / 0.9 ml ·
- Prescription only
- Urinary and reproductive system, hormones
- Active substance
- Atosibanum
- Made by
- Labatec Pharma SA
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Tocolyse entre la 24e et la 33e semaine de grossesse
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Labatec Pharma SA |
|---|---|
| Active substance | Atosibanum |
| Used in | Urinary and reproductive system, hormones |
| Strength | 6.75 mg / 0.9 ml |
| Classification | G02CX01 · Urinary and reproductive system, hormones |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Atosiban Labatec 6.75 mg / 0.9 ml, solution injectable |
| Packs | 1 Durchstechflasche(n) |
| Zulassungsnummer | 69185 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.